Table 9 Cost-effectiveness analysis of mHealth interventions compared to usual care.

From: Clinical efficacy and cost-effectiveness analysis of mobile health interventions in diabetes care: a systematic review and meta-analysis

Study

HbA1c reduction

Total healthcare costs* ($USD)

Incremental cost* (USD)

ICER

I

C

I

C

Warren et al.

− 0.9%

No change

$3781

$4662

$−881 (cost-saving)

$978 saved per percentage-point reduction in HbA1c.

Li et al.

Improved control rates (HbA1c < 7%):

$170.53

$258.83

$− 88.30

(cost-saving)

$− 3.21

74.6%

47.1%

  1. *Costs were converted to standardized US dollars based on the exchange rate for the year of the study conducted.
  2. I = Intervention Group, C = Control Group.
Back to article page